Insiders · Profile

Dubensky Thomas W.

President at Tempest Therapeutics. Filing since 7 Jan 2022. CIK 0001635590

Company

Date

Role

Action

Shares

Amount

Of holding

TPST Tempest Therapeutics, Inc.

7 Jan 2022

President

Bought

2,000

$9.56K

1.8%

1 decision on file.